BBY vs CTXR · P/E 14, rev $18.71B vs rev $7.1M
Best Buy Co. Inc (BBY) versus Citius Pharmaceuticals Inc (CTXR) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Latest reported BBY revenue for 2026-08-01 was $18.71B. Net income was $591.0M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. CTXR currently screens at market cap $13.4M.
Not investment advice. Open the BBY and CTXR stock pages for the full models.
Not investment advice.